Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML

Clinical trial NCT00854945 · COMPLETED

Trial details

NCT number: NCT00854945
Sponsor: Traws Pharma, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Acute Myeloid Leukemia

Start date: 2009-01-01
Primary completion: 2013-09-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.